Keywords: millennium, 2nd-qtr, net, loss, drops, pharmaceuticals, usa
Millennium's 2nd-qtr net loss drops 50%
Article | 02 August 2004
Millennium Pharmaceuticals of the USA saw its second-quarter 2004 netloss fall 50% to $53.9 million, or $0.18 per share. The narrower net loss for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
